These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Ethical considerations involved in randomized controlled trials of gastro-intestinal emergencies. Blum AL; Sonnenberg A Adv Biosci; 1980; 27():79-86. PubMed ID: 11662861 [No Abstract] [Full Text] [Related]
43. Ethics of randomised clinical trials. Giertz G J Med Ethics; 1980 Jun; 6(2):55-7. PubMed ID: 7420368 [No Abstract] [Full Text] [Related]
44. Medical treatment, medical research and informed consent. Gillon R J Med Ethics; 1989 Mar; 15(1):3-5, 11. PubMed ID: 2647993 [No Abstract] [Full Text] [Related]
45. May a human subject waive the right to be treated as a human subject? Novick A AIDS Public Policy J; 1990; 5(1):45-8. PubMed ID: 11650389 [No Abstract] [Full Text] [Related]
46. Physician response to informed consent regulations for randomized clinical trials. Taylor KM; Shapiro M; Soskolne CL; Margolese RG Cancer; 1987 Sep; 60(6):1415-22. PubMed ID: 3621123 [TBL] [Abstract][Full Text] [Related]
47. Ethics and errors of clinical trials and the role and place of different types of trial: introduction. Mathé G; Reizenstein P Drugs Exp Clin Res; 1986; 12(1-2-3):1-9. PubMed ID: 11650151 [No Abstract] [Full Text] [Related]
48. Monitoring for adherence: ethical considerations. Levine RJ Am J Respir Crit Care Med; 1994 Feb; 149(2 Pt 1):287-8. PubMed ID: 8306018 [No Abstract] [Full Text] [Related]
49. Patient or guinea pig? Dilemma of clinical trials. Grady D N Y Times Web; 1999 Jan; ():F1, F4. PubMed ID: 11647579 [No Abstract] [Full Text] [Related]
50. Ethics of drug experimentation. Sgreccia E Dolentium Hominum; 1987; 4(2nd Yr. 1):60-75. PubMed ID: 11653200 [No Abstract] [Full Text] [Related]
51. Statistics and ethics in medical research: study design. Altman DG Br Med J; 1980 Nov; 281(6250):1267-9. PubMed ID: 7000298 [No Abstract] [Full Text] [Related]
52. Randomized controlled trials and randomized control of consent. Somerville MA Health Law Can; 1980; 1(3):58-61. PubMed ID: 10309456 [No Abstract] [Full Text] [Related]
53. A prospective randomized trial of early diagnosis and treatment of cystic fibrosis: a unique ethical dilemma. Fost N; Farrell PM Clin Res; 1989 Sep; 37(3):495-500. PubMed ID: 2673641 [No Abstract] [Full Text] [Related]
54. [The principle of randomization. An attempt at a medico-ethical analysis]. Ornskov F; Gøotzsche PC Ugeskr Laeger; 1988 Apr; 150(15):897-900. PubMed ID: 3363729 [No Abstract] [Full Text] [Related]
55. Personal view: Evans M Br Med J (Clin Res Ed); 1985 Mar; 290(6473):1001. PubMed ID: 11658540 [TBL] [Abstract][Full Text] [Related]
56. Ethics of informed consent. Can Med Assoc J; 1983 Nov; 129(10):1069-70. PubMed ID: 6627156 [No Abstract] [Full Text] [Related]
57. Innovative therapy. The responsibility of hospitals. Cowan DH; Bertsch E J Leg Med; 1984 Jun; 5(2):219-51. PubMed ID: 6611383 [No Abstract] [Full Text] [Related]
58. Advantages and drawbacks of the Zelen design for randomized clinical trials. Horwitz RI; Feinstein AR J Clin Pharmacol New Drugs; 1980 Jul; 20(7):425-7. PubMed ID: 11658484 [No Abstract] [Full Text] [Related]
59. The ethics quagmire and random clinical trials. Tancredi LR Inquiry; 1975 Sep; 12(3):171-9. PubMed ID: 126949 [No Abstract] [Full Text] [Related]
60. Protocol review within the context of a research program. Miller FG; Rosenstein DL IRB; 1998; 20(4):7-10. PubMed ID: 11657088 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]